The University of Chicago Header Logo

Connection

James Vardiman to Patient Selection

Back to Details
This is a "connection" page, showing publications James Vardiman has written about Patient Selection.
James Vardiman
Connection Strength
0.010
Patient Selection
  1. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. Leukemia. 2003 Feb; 17(2):323-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.